CHARLES SCHWAB INVESTMENT MANAGEMENT INC - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 1 filers reported holding EIDOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$9,445,000
+100.3%
71,774
-23.1%
0.00%
+100.0%
Q3 2020$4,716,000
+38.5%
93,327
+30.7%
0.00%0.0%
Q2 2020$3,405,000
+47.1%
71,426
+51.2%
0.00%
+100.0%
Q1 2020$2,314,000
-13.3%
47,226
+1.6%
0.00%0.0%
Q4 2019$2,668,000
+71.2%
46,479
+7.3%
0.00%0.0%
Q3 2019$1,558,000
+6.1%
43,299
-8.3%
0.00%0.0%
Q2 2019$1,469,000
+10.6%
47,243
-16.5%
0.00%0.0%
Q1 2019$1,328,000
+179.0%
56,604
+63.8%
0.00%
Q4 2018$476,000
+51.1%
34,555
+9.6%
0.00%
Q3 2018$315,00031,5340.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$56,777,00018.14%
Board of Trustees of The Leland Stanford Junior University 265,670$13,425,0005.17%
Opaleye Management Inc. 315,550$15,945,0003.12%
RA Capital Management 2,163,271$109,310,0002.00%
Cormorant Asset Management, LP 993,185$50,186,0001.93%
Parkman Healthcare Partners LLC 41,091$2,076,0000.55%
Perceptive Advisors 686,922$34,710,0000.51%
Redmile Group, LLC 466,205$23,557,0000.43%
Eventide Asset Management 317,417$16,039,0000.31%
Ikarian Capital, LLC 63,011$3,184,0000.23%
View complete list of EIDOS THERAPEUTICS INC shareholders